Singapore blocks website selling e-cigarettes disguised as stationery

Oct.22.2024
Singapore blocks website selling e-cigarettes disguised as stationery
Singapore blocks website selling e-cigarettes disguised as stationery after Malaysia reports fake products resembling popular brands.

Singapore has blocked a website selling e-cigarettes disguised as stationery products, following similar cases reported in Malaysia, according to a report in the Straits Times on 22 October.

 

The Public Health Malaysia Facebook page, run by a group of public health experts, posted photos on 3 October reminding parents and teachers to be wary of these e-cigarettes, which resemble popular stationery brands such as markers and glue sticks.

 

On October 21, the media outlet "The Straits Times" discovered that a website selling an e-cigarette resembling a highlighter and capable of delivering to Singapore is inaccessible.

 

A female spokesperson from the Health Sciences Authority (HSA) in Singapore responded to queries from the media by stating that they have collaborated with the Infocomm Media Development Authority to block access for Singapore residents to the Malaysian website.

 

The HSA is aware of a trend overseas where users are modifying the appearance of e-cigarettes to resemble everyday stationery items. We are monitoring these e-cigarettes.

 

The spokeswoman added that from January to September, the HSA removed more than 6,000 illegal e-cigarette-related posts. In addition, HSA is working with e-commerce websites and online platforms such as Instagram, Facebook and Carousell to remove such content as soon as it is detected. She also stated that HSA will track any illegal e-cigarette-related activity on social media platforms and messaging apps.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Smoore International Falls Over 6% Again; H1 Net Profit Down Nearly 28%, Short-Term Profitability Pressured by Higher R&D Spending
Smoore International Falls Over 6% Again; H1 Net Profit Down Nearly 28%, Short-Term Profitability Pressured by Higher R&D Spending
Smoore International (06969) continued to decline after its earnings release, falling more than 6% in early trading today. As of press time, the stock was down 5.08% at HK$19.23, with a turnover of HK$466 million.
Aug.28 by 2FIRSTS.ai
US Democratic Lawmakers Slam FDA’s Juul Approval, Urge Stronger E-Cigarette Regulation
US Democratic Lawmakers Slam FDA’s Juul Approval, Urge Stronger E-Cigarette Regulation
Illinois Rep. Raja Krishnamoorthi and Sen. Dick Durbin condemned the FDA for approving Juul sales, citing the company’s role in youth nicotine addiction. They urged the agency to reverse the decision and tighten e-cigarette regulation.
Jul.22 by 2FIRSTS.ai
ETN: Tracking Regulatory Changes in Tobacco Laws Worldwide
ETN: Tracking Regulatory Changes in Tobacco Laws Worldwide
Since 2024, global tobacco regulation has shown diverging trends: several European countries have imposed flavor bans and disposable vape restrictions; Australia’s “prescription model” faces black market challenges; North America’s stricter flavor controls have sparked market debate; while Asian nations are seeking a balance between economic interests and public health.
Jul.07 by 2FIRSTS.ai
Russian Voronezh Region Website Blocked for Illegal Tobacco Advertising
Russian Voronezh Region Website Blocked for Illegal Tobacco Advertising
A court in Russia’s Voronezh region has ruled to block online distribution of illegal tobacco sales content in a move to protect public health.
Jul.15 by 2FIRSTS.ai
Japan Tobacco’s Greece Subsidiary Posts $900 Million Revenue in 2024, Plans to Boost Ploom Market Expansion
Japan Tobacco’s Greece Subsidiary Posts $900 Million Revenue in 2024, Plans to Boost Ploom Market Expansion
Japan Tobacco International’s (JTI) Greece operations are projected to generate over €800 million (approximately $900 million) in revenue in 2024, with a net profit of €958,000 (about $1.11 million), marking a growth in market share despite challenging conditions. JTI’s innovation is driving market expansion in Greece, with its Ploom products successfully entering the market.
Jul.18 by 2FIRSTS.ai
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
The U.S. FDA will review Philip Morris International’s renewal application for five IQOS products' modified risk status at an October 7 TPSAC meeting, evaluating whether they still meet the required standards.
Jul.30 by 2FIRSTS.ai